SCHEMBL6096045

SCHEMBL6096045

NN=Cc1ccnc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.51
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
HPGD P15428 5/20 0.51
ALDH1A1 P00352 5/20 0.51
CYP1A2 P05177 3/20 0.51
MAPK1 P28482 2/20 0.51
CYP2C19 P33261 2/20 0.51
HSD17B10 Q99714 2/20 0.51
KDM4E B2RXH2 2/20 0.51
CYP2C9 P11712 1/20 0.51
ALOX15 P16050 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RAB9A P51151 5/20 0.50
HTT P42858 3/20 0.50
NCF1 P14598 1/20 0.50
NPC1 O15118 4/20 0.49
GAA P10253 2/20 0.49
LMNA P02545 1/20 0.49
CASP3 P42574 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5289576 1.00 MAPT (0.51) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL15841249 0.81 MAPT (0.53) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL3652495 0.81 MAPT (0.53) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL3652492 0.81 MAPT (0.53) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL12757021 0.77 MEN1 (0.49) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL6746931 0.75 MEN1 (0.60) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL6746928 0.75 MEN1 (0.60) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL3160770 0.75 MAPT (0.56) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL3090738 0.75 MAPT (0.56) MAPTMEN1KMT2AHPGDALDH1A1
SCHEMBL333756 0.75 MAPT (0.56) MAPTMEN1KMT2AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0218689-B1 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS THE UPJOHN COMPANY (US) 1990-08-01 EP claimed
EP-0263209-A2 Anthelmintic quinolinyl acylhydrazones THE UPJOHN COMPANY (US) 1988-04-13 EP claimed
WO-1986005982-A3 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-04-23 WO claimed
EP-0218689-A1 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS. UPJOHN CO (US) 1987-04-22 EP claimed
WO-1986005982-A2 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS UPJOHN CO (US) 1986-10-23 WO claimed
US-7112391-B2 Electrophotographic organophotoreceptors with novel charge transport compounds SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-09-26 US disclosed
US-20050074683-A1 Electrophotographic organophotoreceptors with novel charge transport compounds SAMSUNG ELECTRONICS CO., LTD. 2005-04-07 US disclosed
US-6613942-B1 Nonpeptide; 4-hydroxy benzoic acid hydrazides NOVO NORDISK A/S (DK) 2003-09-02 US disclosed
EP-0218689-B1 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS THE UPJOHN COMPANY (US) 1990-08-01 EP disclosed
US-4870082-A PARASITICIDES, NEMATOCIDES THE UPJOHN COMPANY (US) 1989-09-26 US disclosed
EP-0263209-A2 Anthelmintic quinolinyl acylhydrazones THE UPJOHN COMPANY (US) 1988-04-13 EP disclosed
WO-1986005982-A3 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-04-23 WO disclosed
EP-0218689-A1 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS. UPJOHN CO (US) 1987-04-22 EP disclosed
WO-1986005982-A2 ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS UPJOHN CO (US) 1986-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050074683-A1 Electrophotographic organophotoreceptors with novel charge transport compounds SLC18A2, SLC43A1, SLC1A2 MAPT 3401/4885MEN1 2704/4885KMT2A 2476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.